Related Articles Physician-assisted suicide, euthanasia and palliative sedation: attitudes and knowledge of medical students. GMS J Med Educ. 2016;33(1):Doc11 Authors: Anneser J, Jox RJ, Thurn T, Borasio GD Abstract OBJECTIVES: In November 2015, the German Federal Parliament voted on a new legal regulation regarding assisted suicide. It was decided to amend the German Criminal Code so that any «regular, repetitive offer» (even on a non-profit basis) of assistance in suicide would now be considered a punishable offense. On July 2, 2015, a date which happened to be accompanied by great media interest in that it was the day that the…
Origen: Physician-assisted suicide, euthanasia and palliative sedation: attitudes and knowledge of medical students. – PubMed

Related Articles Combined endovascular brachytherapy, sorafenib, and transarterial chemobolization therapy for hepatocellular carcinoma patients with portal vein tumor thrombus. World J Gastroenterol. 2017 Nov 21;23(43):7735-7745 Authors: Zhang ZH, Liu QX, Zhang W, Ma JQ, Wang JH, Luo JJ, Liu LX, Yan ZP Abstract AIM: To evaluate the safety and efficacy of combined endovascular brachytherapy (EVBT), transarterial chemoembolization (TACE), and sorafenib to treat hepatocellular carcinoma (HCC) patients with main portal vein tumor thrombus (MPVTT). METHODS: This single-center retrospective study involved 68 patients with unresectable HCC or those who were unfit for liver transplantation and percutaneous frequency ablation according to the BCLC…
Origen: Combined endovascular brachytherapy, sorafenib, and transarterial chemobolization therapy for hepatocellular carcinoma patients with portal vein tumor thrombus. – PubMed

Related Articles [High-intensity chemotherapy versus palliative chemotherapy in patients over 60 years with acute myeloid leukemia]. Rev Med Inst Mex Seguro Soc. 2016;54 Suppl 2:S148-55 Authors: Medrano-Contreras J, Talavera-Piña JO, Guerrero-Rivera S, Gutiérrez-Espíndola GR, Gómez-Cortés C, Pérez-Rocha JF, Terreros-Muñoz E, Meillón-García LA Abstract BACKGROUND: The use of high-intensity chemotherapy (HIC) for acute myeloid leukemia (AML) in the elderly is controversial. In the present study, it was assessed complete remission and overall survival of AML patients over 60 years treated with HIC or palliative chemotherapy. METHODS: Patients with ECOG ≤ 2 and adequate organic function received HIC with a base of…
Origen: [High-intensity chemotherapy versus palliative chemotherapy in patients over 60 years with acute myeloid leukemia]. – PubMed